Market Overview

VirnetX Tumbles Despite Gilford Reiteartion


Shares of VirnetX (NYSE: VHC) dropped over 10% on Friday despite getting defended at Gilford Securities. The firm reiterated its Buy rating and $65 price target.

A jury ruled Thursday that while VirnetX's patents are valid, Cisco (NASDAQ: CSCO) did not infringe upon them.

VirnetX has been a controversial company for some time. Along with that controversy, shares have been on a rollercoaster ride: trading as high as $40 and as low as $15. The company is widely known as a patent troll -- the company really makes no products of its own, instead using its patent portfolio to bring lawsuits against major tech companies.

Shares of VirnetX traded near $22.70 on Friday.


Related Articles (VHC + CSCO)

View Comments and Join the Discussion!

Posted-In: News Reiteration Legal Intraday Update Analyst Ratings Movers

Latest Ratings

CHGGMorgan StanleyMaintains105.0
CGMorgan StanleyMaintains38.0
BXMorgan StanleyMaintains78.0
APOMorgan StanleyMaintains55.0
RUTHRaymond JamesMaintains23.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at